Chatter around psilocybin was at a fever pitch early this year, as a growing choir of voices cheered the potential for the psychedelic component of “magic mushrooms” to treat a bevy of difficult diseases and conditions where traditional drugs have failed miserably. The roars of newness may have calmed down, but the opportunity is alive and well. In fact, it is quietly gaining steam as research accelerates with the fascinating class of compounds.
While still illegal at the federal level in the U.S. as a Schedule I drug, proponents are hopeful that one day psilocybin will be re-classified as having medical purposes. The compound has a similar label in Canada, designating it as having no medical use. However, there are many anecdotal cases where psilocybin has provided a great therapeutic benefit for a spectrum of patients, including those with advanced cancer.
Select companies are taking the lead to conduct research … Read the rest